Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England. (2021)
Attributed to:
Phase 1 COVID-19 Immunity - National Core Study
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41467-021-27410-5
PubMed Identifier: 34893611
Publication URI: http://europepmc.org/abstract/MED/34893611
Type: Journal Article/Review
Volume: 12
Parent Publication: Nature communications
Issue: 1
ISSN: 2041-1723